Skip to content

LYSERGIC ACID DIETHYLAMIDE AS A VARIABLE IN THE HOSPITAL TREATMENT OF ALCOHOLISM

William T. Bowen, Robert A. Soskin, John W. Chotlos

The Journal of Nervous and Mental Disease February 1, 1970 DOI: 10.1097/00005053-197002000-00003 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Controlled study Peer reviewed
Population Patients in a Human Relations Training Laboratory treatment program for alcoholism
Intervention Lysergic acid diethylamide (LSD)
Topics LSD
Keywords Placebo Dose Concomitant Pharmacology Alternative medicine
Citations 68
Key points Long-term gains through use of LSD are negligible; successful adjustment is more closely associated with pretreatment employment level, marital status, and completing the treatment program.

Abstract

The use of lysergic acid diethylamide (LSD) in the treatment of alcoholism has led to many claims as to the drug's efficacy, but without a controlled study of both in-hospital application and posthospital adjustment of patients. The present paper is concerned with the use of LSD in placebo and maximum dosages as a concomitant of a Human Relations Training Laboratory treatment program. Patients receiving LSD were also compared with patients completing the Laboratory program but not receiving LSD. Findings were such as to indicate that the long term gains through use of LSD are negligible. A successful post-treatment adjustment seems more closely associated with pretreatment employment level, marital status, and whether or not the patient completes the treatment program.

Explore topics